Literature DB >> 15028315

Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit.

E D Mulligan1, B Dunne, M Griffin, N Keeling, J V Reynolds.   

Abstract

AIMS: Positive microscopic margins after major cancer surgery adversely affect prognosis. We questioned whether the benefit of a multimodal approach in oesophageal carcinoma is due to reduced resection margin involvement and whether multimodal therapy alters the disease course when margins are involved.
METHODS: Pathology specimens of 212 patients, treated with either multimodal therapy or surgery alone, were re-reviewed to assess margin involvement by tumour. Margin status was compared with recurrence and survival data.
RESULTS: Margin involvement was decreased with multimodal therapy (16 of 103 patients) vs surgery (33 of 109 patients), associated with reduced tumour recurrence and a significant survival advantage. However, even with involved margins, multimodal therapy had lower recurrence vs surgery and a small survival benefit.
CONCLUSIONS: Multimodal therapy significantly reduces margin involvement. The benefit of multimodal therapy remains highly significant for patients with clear margins. This study confirms for oesophageal carcinoma the value of an aggressive surgical approach in achieving negative resection margins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028315     DOI: 10.1016/j.ejso.2003.11.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  14 in total

1.  Unexpected Microscopically Positive Proximal Resection Margins in Esophageal Squamous Cell Carcinoma After Chemoradiotherapy: Predictors and Prognostic Significance.

Authors:  Chien-Hung Chiu; Yin-Kai Chao; Yu-Wen Wen; Hsien-Kun Chang; Chen-Kan Tseng; Yun-Hen Liu
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

2.  A study of contractility of proximal surgical margin in esophageal cancer.

Authors:  Jalaluddin Khoshnevis; Afshin Moradi; Eznollah Azargashb; Barmak Gholizade; Mohammad Reza Sobhiyeh
Journal:  Iran J Cancer Prev       Date:  2013

Review 3.  Oncologic Quality Indicators in Thoracic Surgery.

Authors:  Jessica Hudson; Tara Semenkovich; Varun Puri
Journal:  Thorac Surg Clin       Date:  2017-08       Impact factor: 1.750

4.  Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins.

Authors:  Sarah J Gao; Henry S Park; Christopher D Corso; Charles E Rutter; Sajid A Khan; Kimberly L Johung
Journal:  J Gastrointest Oncol       Date:  2017-12

5.  Using Genomics Feature Selection Method in Radiomics Pipeline Improves Prognostication Performance in Locally Advanced Esophageal Squamous Cell Carcinoma-A Pilot Study.

Authors:  Chen-Yi Xie; Yi-Huai Hu; Joshua Wing-Kei Ho; Lu-Jun Han; Hong Yang; Jing Wen; Ka-On Lam; Ian Yu-Hong Wong; Simon Ying-Kit Law; Keith Wan-Hang Chiu; Jian-Hua Fu; Varut Vardhanabhuti
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

6.  Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist.

Authors:  Ewen A Griffiths; Susan A Pritchard; Nicholas P Mapstone; Ian M Welch
Journal:  World J Surg Oncol       Date:  2006-11-21       Impact factor: 2.754

7.  Role of postoperative radiotherapy for microscopic margin involvement in the squamous cell carcinoma of esophagus.

Authors:  Sanghyuk Song; Eui Kyu Chie; Hak Jae Kim; Chang-Hyun Kang; Young Tae Kim; Joo Hyun Kim; Charn Il Park
Journal:  Cancer Res Treat       Date:  2013-09-30       Impact factor: 4.679

8.  A critical appraisal of circumferential resection margins in esophageal carcinoma.

Authors:  Bareld B Pultrum; Judith Honing; Justin K Smit; Hendrik M van Dullemen; Gooitzen M van Dam; Henk Groen; Harry Hollema; John Th M Plukker
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

9.  A highly active and tolerable neoadjuvant regimen combining paclitaxel, carboplatin, 5-FU, and radiation therapy in patients with stage II and III esophageal cancer.

Authors:  L van de Schoot; E A P M Romme; M J van der Sangen; G J Creemers; G van Lijnschoten; O J Repelaer van Driel; H J T Rutten; G A P Nieuwenhuijzen
Journal:  Ann Surg Oncol       Date:  2007-09-26       Impact factor: 5.344

10.  The impact of operative approach on outcome of surgery for gastro-oesophageal tumours.

Authors:  Stuart A Suttie; Alan Gk Li; Martha Quinn; Kenneth Gm Park
Journal:  World J Surg Oncol       Date:  2007-08-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.